GSK and Save the Children form unique partnership to save the lives of one million children
An ambitious new partnership to save the lives of a million of the poorest children in the world has been launched by GSK and Save the Children. This unique collaboration will see the two organisation…Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis
Novartis announced that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged 2 ye…Tags: food and drug administration fda, juvenile idiopathic arthritis, us food and drug administration
